Physician profile
Tara Moore
NPI 1740608884
$15,109.63
in general payments reported to CMS, 2019-2025
17 companies · $38.71 in 2025
The $38.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.15 · 2020: $154 · 2021: $403 · 2022: $231 · 2023: $14K · 2024: $14.95 · 2025: $38.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Travel and Lodging: $3,001 · Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,500.00 |
| Travel and Lodging | $3,000.58 |
| Food and Beverage | $731.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,864.42 | 2023 | Davinci Xi, Da Vinci Sp, Da Vinci Surgical System |
| Abbvie INC. | $439.71 | 2019-2022 | |
| Medtronic, INC. | $114.55 | 2021-2023 | Truclear |
| Organon LLC | $93.99 | 2021-2025 | Nexplanon, Nuvaring |
| Exeltis, USA INC. | $83.48 | 2020-2023 | Slynd |
| Mayne Pharma Commercial LLC | $79.12 | 2021-2023 | |
| Therapeuticsmd, INC. | $68.37 | 2020-2022 | |
| Myriad Women'S Health, INC. | $66.35 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $62.52 | 2022-2023 | Thinprep 2000 Processor, Aptima, Third Wave |
| Astellas Pharma US INC | $53.40 | 2023 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $52.25 | 2020-2023 | |
| Pfizer INC. | $47.83 | 2020-2024 | |
| Smith+Nephew, INC. | $21.04 | 2025 | Pico 7 |
| Amgen INC. | $20.66 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.34 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $13.62 | 2022 | |
| Becton, Dickinson and Company | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.